BioImagene Inc, the leading provider of end-to-end digital pathology solutions, today announced the availability of Companion Algorithms for colon cancer in their Virtuoso digital pathology software.
Read MoreDiagnoCure Inc announced that the clinical utility of the PROGENSA PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline’s REDUCE trial of dutasteride.
Read MoreMyriad Genetics Inc announces the launch of PROLARIS, a 46-gene prognostic test which quantitatively determines the risk of recurrence in patients who have undergone prostatectomy surgery.
Read MoreSpecific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read More
An interview with Keith Chaitoff, Divisional Vice President, US Marketing
Read More